<DOC>
	<DOCNO>NCT01207115</DOCNO>
	<brief_summary>To compare analgesic efficacy safety ABT-652 administer twice daily ( BID ) placebo subject osteoarthritis ( OA ) knee .</brief_summary>
	<brief_title>A Study ABT-652 Adults With Osteoarthritis Pain Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Inclusion Criteria History OA knee joint meeting American College Rheumatology ( ACR ) Clinical Radiographic criterion , Pain score require protocol Screening Baseline Willing washout analgesic follow treatment plan , visit schedule study procedure . Exclusion Criteria History sensitivity histamine medication , acetaminophen ( paracetamol ) , nonsteroidal antiinflammatory drug ( NSAIDs ) Active gastrointestinal ( GI ) disease , GI bleed GI ulceration , history GI bleeding GI ulceration last 6 month History major psychiatric disorder Diagnosis rheumatoid arthritis , autoimmune disorder , arthritis osteoarthritis involve study joint , painful syndrome could interfere assessment pain study joint Any cardiac , respiratory , neurological medical condition illness well control treatment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>